نتایج جستجو برای: chronic thromboembolic pulmonary hypertension

تعداد نتایج: 788645  

Journal: :Advances in pulmonary hypertension 2022

Advanced practice nurses play an integral role in the management of chronic thromboembolic pulmonary hypertension patients undergoing thromboendarterectomy and balloon angioplasty. As members multidisciplinary team, advance assist presurgical, postsurgical, procedural settings by ensuring appropriate referral, workup, evaluation, education.

2017
Cihan Örem

Pulmonary hypertension (PH) is a haemodynamic and pathophysiological condition defined as increase in mean pulmonary arterial pressure ≥ 25 mmHg at rest as assessed by right heart catheterization (RHC). It can be due to a primary elevation of pressure in the pulmonary arterial system alone (pulmonary arterial hypertension), or secondary to elevations of pressure in the pulmonary venous and capi...

Journal: :Circulation: Cardiovascular Quality and Outcomes 2017

Journal: :Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 2005
Kyriakos S Rammos

hypertension (CTEPH) develops in 1-3% of cases following acute pulmonary embolism. The disease is underdiagnosed and under-treated, as statistical studies have shown. Identification of patients with CTEPH is difficult since 90% of them have no apparent disturbance of the coagulation mechanism. CTEPH is a progressive disease, the result of the incomplete lysis of large organised thrombus in the ...

2014
Vikram Shenoy James M. Anton Charles D. Collard Sloan C. Youngblood

1255 May 2014 C HRONIC thromboembolic pulmonary disease is an important cause of severe pulmonary hypertension and is associated with significant morbidity and mortality. At 2-yr follow-up, 3.8% of survivors of an acute pulmonary embolic event develop chronic thromboembolic pulmonary hypertension (CTEPH) defined as a persistent mean pulmonary arterial pressure greater than 25 mmHg for 6 months ...

Journal: :The European respiratory journal 2015
Rogerio Souza Steven M Kawut

This issue of the European Respiratory Journal includes the results of three different studies of riociguat, a soluble guanylate cyclase stimulator, for the treatment of pulmonary hypertension [1–3]. As the first drug in a novel class for the treatment of pulmonary hypertension, riociguat has raised hopes of an expanded drug armamentarium against the still incurable diseases of pulmonary arteri...

2012
William R. Auger Kim M. Kerr Nick H. Kim Peter F. Fedullo

Pulmonary hypertension as a result of chronic thromboembolic disease (CTEPH) is potentially curable with pulmonary endarterectomy surgery. Consequently, correctly diagnosing patients with this type of pulmonary hypertension and evaluating these patients with the goal of establishing their candidacy for surgical intervention is of utmost importance. And as advancements in surgical techniques hav...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید